World Health Organization forecasts 25% fewer Covid vaccines for the world this year than earlier hoped

WHO covid vaccine forecast

The World Health Organization's vaccine-sharing program COVAX forecasts an additional 1.1 billion Covid-19 vaccine doses will be made available globally between now and the end of the year, fewer than previously estimated.

This forecast, released Wednesday, projects 25% fewer doses compared to July's forecast. The new projection prompted a fresh call from WHO for rich countries to hold off on giving boosters until more people around the world can get their first doses of vaccine.

Currently, 330 million doses have been released for delivery to underserved countries through COVAX, and 230 million have been delivered to member countries.

In what the report calls the "most likely scenario" for vaccine supply through the end of the year, more than a billion more doses will be made available between September and the end of the year.

"We expect to have a further 1.1 billion doses available for delivery between now and the end of the year," Dr Seth Berkley, CEO of GAVI, one of the groups that makes up COVAX, said in a media briefing. Doses will be targeted to 92 lower-income countries.

This prediction would put total vaccine availability in all of 2021 at 1.4 billion doses, with 1.2 billion available for low-income countries.The most recent forecast from July predicted 1.8 billion total available vaccines in 2021. The new COVAX analysis cited export restrictions in India, manufacturing issues with AstraZeneca facilities, Novavax regulatory delays, and pending approval of Chinese biopharmaceutical company Clover's vaccine as driving the decline, in addition to production issues with Johnson & Johnson's vaccine.

"Production issues at J&J's Emergent facility (which is assigned to supply COVAX) have led to delays," the report reads. Emergent's Baltimore vaccine plant stopped production for months after a mix-up earlier this year involving ingredients for the J&J and AstraZeneca vaccines.

"While production has now restarted, the manufacturing ramp-up combined with the backlog of orders for other bilateral customers has led to delayed timelines and lower volumes that will be made available to COVAX in 2021."
According to the report, 180 million of the doses lost between the July forecast and the September forecast were to have been supplied by Johnson & Johnson.
The forecast does indicate more doses will be available from two sources: an expected gain of 20 million doses from China's Sinopharm and an additional 95 million doses in the form of donations.

I will not stay silent

WHO Director-General Tedros Adhanom Ghebreyesus reiterated his call for wealthy nations to refrain from boosting their Covid-19 vaccinations until shots are available to more of the world -- this time, asking countries to wait until at least the end of the year, rather than the end of September.

"A month ago, I called for a global moratorium on booster doses, at least until the end of September, to prioritize vaccinating the most at-risk people around the world who are yet to receive their first dose. There has been little change in the global situation since then," Tedros said during a media briefing on Wednesday.

"So today, I'm calling for an extension of the moratorium, until at least the end of the year, to enable every country to vaccinate at least 40% of its population."

Tedros acknowledged that third doses may be needed for those most at risk who see their immunity wane, "but for now, we do not want to see widespread use of boosters for healthy people who are fully vaccinated."

Tags : #WHO #WHOVaccineForecast #Covax #Gavi #AstraZeneca #JohnsonandJohnson

About the Author

Team Medicircle

Related Stories

Loading Please wait...


Trending Now

Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023
Global Corporate Summit 2023 with the theme Unlocking Opportunities in a Dynamic World heldNovember 16, 2023
2nd IHub-Data Mobility Summit heldNovember 16, 2023
Revolutionary AI-powered technology detects multiple abdominal pathologies simultaneouslyNovember 16, 2023
1 Out of 3 Stroke Patients Suffer Long-Term Health Complications, Says NeurologistNovember 16, 2023
Amrita Hospital, Kochi, Launches App for People with Swallowing DifficultiesNovember 15, 2023